COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 1697: Articles 16961-16970  | Next

Tocilizumab efficacy in COVID-19 patients is associated with respiratory severity-based stages
Alvarez-Mon, M., Asunsolo, A., Sanz, J., Munoz, B., Arranz-Caso, J. A., Novella Mena, M., Hernandez-Gutierrez, C., Navarro, J., Lozano Duran, M. C., Arevalo Serrano, J., Heche Sanchez, R., Bravo Quiroga, L., Flores Segovia, J., Garcia Sanchez, M., Gutierrez Garcia, A., Perez, A., Herrero, M., Plana, N., Troncoso, D., Rackov, G., Martinez-A, C., Balomenos, D.
10.1101/2021.03.04.21252167 — Posted: 2021-03-09
AI-driven prediction of SARS-CoV-2 variant binding trends from atomistic simulations
Capponi, S., Wang, S., Bianco, S.
10.1101/2021.03.07.434295 — Posted: 2021-03-08
Genome-Wide Covariation in SARS-CoV-2
Cresswell-Clay, E. C., Periwal, V.
10.1101/2021.03.08.434363 — Posted: 2021-03-08
Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses
Zhou, H., Ji, J., Chen, X., Bi, Y., Li, J., Hu, T., Song, H., Chen, Y., Cui, M., Zhang, Y., Hughes, A. C., Holmes, E. C., Shi, W.
10.1101/2021.03.08.434390 — Posted: 2021-03-08 Discussion: Offsite
Structural Analysis of Spike Protein Mutations in an Emergent SARS-CoV-2 Variant from the Philippines
Bascos, N. A. D., Mirano-Bascos, D., Saloma, C. P.
10.1101/2021.03.06.434059 — Posted: 2021-03-08 Discussion: Onsite
Comparative studies of the seven human coronavirus envelope proteins using topology prediction and molecular modelling to understand their pathogenicity
Schoeman, D., Cloete, R., Fielding, B.
10.1101/2021.03.08.434384 — Posted: 2021-03-08
Comparative host interactomes of the SARS-CoV-2 nonstructural protein 3 and human coronavirus homologs
Almasy, K. M., Davies, J. P., Plate, L.
10.1101/2021.03.08.434440 — Posted: 2021-03-08
Sialic acid-Dependent Binding and Viral Entry of SARS-CoV-2
Nguyen, L., McCord, K. A., Bui, D. T., Bouwman, K. A., Kitova, E. N., Kumawat, D., Daskan, G. C., Tomris, I., Han, L., Chopra, P., Yang, T.-J., Williows, S. D., Lowary, T. L., West, L. J., Hsu, S.-T. D., Tompkins, S. M., Boons, G.-J., Mason, A. L., de Vries, R. P., Macauley, M. S., Klassen, J. S.
10.1101/2021.03.08.434228 — Posted: 2021-03-08
SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection
Bashor, L., Gagne, R. B., Bosco-Lauth, A., Bowen, R., Stenglein, M., VandeWoude, S.
10.1101/2021.03.05.434135 — Posted: 2021-03-08
Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract
Alfi, O., Yakirevich, A., Wald, O., Wandel, O., Izhar, U., Oiknine-Djian, E., Nevo, Y., Elgavish, S., Dagan, E., Madgar, O., Feinmesser, G., Pikarsky, E., Bronstein, M., Vorontsov, O., Jonas, W., Ives, J., Walter, J., Zakay-Rones, Z., Oberbaum, M., Panet, A., Wolf, D. G.
10.1101/2021.03.08.434404 — Posted: 2021-03-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).